Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States미국에서 소아 폐렴구균 결합 백신에 대한 의료 제공자들의 선호 속성 이해Article Published on 2024-12-312024-08-24 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] Attitudes behaviors discrete choice experiment knowledge Pediatric vaccines pneumococcal conjugate vaccines pneumococcal disease provider preferences. survey
Vaccines for the Elderly and Vaccination Programs in Europe and the United StatesReview Published on 2024-05-222024-09-05 Journal: Vaccines [Category] update2024, [키워드] COVID-19 herpes zoster immunization immunosenescence Influenza Older adults pneumococcal disease respiratory syncytial virus (RSV) vaccination programs [DOI] 10.3390/vaccines12060566 PMC 바로가기 [Article Type] Review
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older50세 이상의 미국 성인을 위한 개발 중인 성인용 21가 폐렴구균 결합 백신의 비용 효과성Article Published on 2024-04-302024-08-24 Journal: Vaccine [Category] 폐렴구균 감염증, [키워드] Adults cost-effectiveness PCV21 pneumococcal disease societal perspective. [DOI] 10.1016/j.vaccine.2024.04.002
Emerging pneumococcal serotypes in Iraq: scope for improved vaccine developmentarticle Published on 2023-12-312024-09-01 Journal: F1000Research [Category] 폐렴구균 감염증, [키워드] Iraq pneumococcal disease Pneumococcal serotypes pneumococcal vaccines serotype replacement [Article Type] article
Infant mortality rates and pneumococcal vaccines: a time-series trend analysis in 194 countries, 1950-2020article Published on 2023-08-312024-09-01 Journal: BMJ Glob Health [Category] 폐렴구균 감염증, [키워드] child health immunisation pneumococcal disease Vaccines [Article Type] article
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C15가 폐렴구균 결합 백신 V114는 폐렴구균 혈청형 6C에 대한 교차 반응 항체를 유도합니다.Article Published on 2023-08-012024-08-24 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] 15-valent PCV cross-reactive antibodies OPA Opsonophagocytic activity pneumococcal disease pneumococcal vaccine Streptococcus pneumoniae V114
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age중국의 6세 이하 유아와 어린이를 대상으로 한 13가 폐렴구균 결합 백신의 안전성과 면역원성을 평가하는 무작위, 공개 라벨, 3상 연구Article Published on 2023-08-012024-08-24 Journal: Human vaccines & immunotherapeutics [Category] 폐렴구균 감염증, [키워드] China clinical trial immunogenicity PCV13 pediatric pneumococcal conjugate vaccine pneumococcal disease Safety Streptococcus pneumoniae
Serotypes and antimicrobial resistance of Streptococcus pneumoniae in children under 5 years of age pre- and post-pneumococcal conjugate vaccine introduction in Paraguayarticle Published on 2023-06-302024-09-01 Journal: British Journal of Pain [Category] 폐렴구균 감염증, [키워드] antimicrobial susceptibility Conjugate vaccines pneumococcal disease Streptococcus pneumoniae [Article Type] article
Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in IraqReview Published on 2023-05-292024-09-05 Journal: International Journal of General Medicine [Category] update2024, [키워드] Iraq pneumococcal disease pneumococcal disease-prevention strategies Pneumococcal pneumonia pneumococcal vaccines Streptococcus pneumoniae [DOI] 10.2147/IJGM.S409476 PMC 바로가기 [Article Type] Review
Pneumococcal vaccination coverage in individuals (16–59 years) with a newly diagnosed risk condition in Germany독일에서 새로 진단된 위험 질환이 있는 개인(16–59세)의 폐렴구균 백신 접종률Article Published on 2022-09-282024-07-28 Journal: BMC Infectious Diseases [Category] 폐렴구균 감염증, [키워드] Claims data Germany PCV13 pneumococcal conjugate vaccine pneumococcal disease pneumococcal vaccination PPSV23 Vaccine coverage rate [DOI] 10.1186/s12879-022-07736-1 PMC 바로가기